Privium Fund Management B.V. Pro Qr Therapeutics N.V. Put Options Transaction History
Privium Fund Management B.V.
- $436 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRQR
# of Institutions
80Shares Held
40MCall Options Held
10.7KPut Options Held
24.1K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.6MShares$21.7 Million0.05% of portfolio
-
Woodline Partners LP San Francisco, CA3.56MShares$8.04 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$6.39 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.83MShares$6.38 Million1.38% of portfolio
-
Ubs Group Ag2.31MShares$5.22 Million0.0% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $161M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...